SCHEMBL18179064

SCHEMBL18179064

CC(=O)c1ncc(C)c(C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
POLB P06746 4/20 0.34
RAB9A P51151 1/20 0.34
APLNR P35414 1/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
SORT1 Q99523 1/20 0.32
SORD Q00796 1/20 0.32
HPGD P15428 3/20 0.32
GAA P10253 1/20 0.31
ALDH1A1 P00352 5/20 0.31
KDM4E B2RXH2 1/20 0.31
HTT P42858 1/20 0.31
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2790057 0.83 HPGD (0.39) SMN1; SMN2SORT1HPGDALDH1A1KDM4E
SCHEMBL14983663 0.81 POLB (0.40) POLBNOS3NOS1NOS2SORT1
SCHEMBL1661890 0.79 SMN1; SMN2 (0.40) SMN1; SMN2POLBRAB9AAPLNRSORD
SCHEMBL30326005 0.79 RAB9A (0.38) SMN1; SMN2POLBRAB9AAPLNRSORD
SCHEMBL14983664 0.78 CNR1 (0.38) SMN1; SMN2SORT1HPGDGAAALDH1A1
SCHEMBL19485123 0.78 NPSR1 (0.40) RAB9AHPGDALDH1A1KDM4EMAPK1
SCHEMBL11723864 0.77 EGFR (0.34) SMN1; SMN2SORT1HPGDALDH1A1KDM4E
SCHEMBL19485124 0.76 P2RX7 (0.47) SMN1; SMN2POLBSORT1GAAALDH1A1
SCHEMBL8582659 0.72 ALDH1A1 (0.33) APLNRALDH1A1KDM4E
SCHEMBL25560063 0.72 PLAU (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160311826-A1 SGC STIMULATORS CYCLERION THERAPEUTICS, INC. 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311826-A1 SGC STIMULATORS GUCY1A1, GUCY1B1, GUCY1A2 SMN1; SMN2 2672/4885POLB 4120/4885RAB9A 2676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.